In 20 years cell and gene therapies for cancer will be commonplace

Cancer is one of the world’s most devastating diseases. Its treatment can be punishing, and have several nasty side effects. Fortunately, scientists have a better idea now of how to treat it, and the experimental techniques being used now may be commonplace in the future. At least, that’s what many experts think. Host Rudy van Beurden has invited three guests who are experts in this field: Jacqueline Barry, Chief Clinical Officer at CT Catapult; Erik Manting, CEO at Immunicum AB and Trudy Straetemans, Assistant Professor at UMC Utrecht. Do you want to learn more about these speakers or this podcast? Check out kadans.com/podcast.kadans, cancer, cell therapy, gene therapy, disease, experimental Building the Future is brought to you by Kadans Science Partner.

You can listen to In 20 years cell and gene therapies for cancer will be commonplace online on Radio and Podcast. Open the player on this page to stream the available audio.

In 20 years cell and gene therapies for cancer will be commonplace is an episode from Building the Future by Kadans Science Partner.

This episode is 41:31 long.

This episode was published on Sep 6, 2021.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Building the Future when more episodes are available from the podcast feed.